Brain-derived neurotrophic factor (BDNF) changes in the serum of depressed women

Progress in Neuro-psychopharmacology & Biological Psychiatry
Cigdem AydemirErol Goka

Abstract

Neuroplastic processes are thought to be involved in the pathophysiology of many psychiatric disorders, including major depression. It has been hypothesized that the brain-derived neurotrophic factor (BNDF), a key factor in neuroplasticity, is associated with depressive disorders. Our study evaluated the pre- and post-treatment levels of BDNF in a group of depressed patients and compared them with healthy controls. In order to exclude the effects of gender on neuroplasticity, our study group was restricted to women exclusively and consisted of 20 depressive patients and 20 healthy controls, with similar age and educational level distribution. Blood samples were collected before the treatment and on the sixth week of the treatment with 10 mg S-citalopram. The pre-treatment BDNF levels of the depressed patients were found to be lower than those of the healthy subjects. During the sixth week, the BDNF levels of depressive patients were significantly higher than the pre-treatment levels but similar to those of control subjects. These findings suggest that BDNF level may be an important factor in the etiopathogenesis of depression and may have a role in the action mechanism of antidepressant drugs.

Associated Clinical Trials

References

Aug 1, 1988·Archives of General Psychiatry·J B Williams
Nov 21, 1995·Proceedings of the National Academy of Sciences of the United States of America·F SohrabjiC D Toran-Allerand
Oct 27, 1995·Science·H Thoenen
Nov 14, 1994·Annals of the New York Academy of Sciences·B S McEwen
Jan 1, 1996·Seikagaku. The Journal of Japanese Biochemical Society·Y FurukawaK Hayashi
Jan 1, 1996·Annual Review of Neuroscience·G R Lewin, Y A Barde
Jan 1, 1997·Pharmacology, Biochemistry, and Behavior·J A SiuciakR M Lindsay
Apr 24, 1997·Nature·W C DrevetsM E Raichle
Jul 1, 1997·Archives of General Psychiatry·R S DumanE J Nestler
Oct 2, 1998·Biological Psychiatry·R S Duman
Apr 2, 1999·Trends in Pharmacological Sciences·C A Altar
Jan 5, 2000·The American Journal of Psychiatry·J D BremnerD S Charney
Mar 18, 2000·Psychological Medicine·E MervaalaJ Lehtonen
May 1, 2001·Nature Medicine·H K ManjiD S Charney
Apr 3, 2002·Psychiatry Research·Félicien KaregeJean-Michel Aubry
May 2, 2002·Proceedings of the National Academy of Sciences of the United States of America·Annette Gärtner, Volker Staiger
May 23, 2002·Recent Progress in Hormone Research·Bruce McEwen
Aug 16, 2002·Bipolar Disorders·Maurizio PopoliGiorgio Racagni
Jul 28, 2004·International Review of Psychiatry·J L Payne
Dec 9, 2004·Neurobiology of Aging·Marek LommatzschJohann Christian Virchow
Jan 26, 2005·Trends in Neurosciences·Helen E Scharfman, Neil J Maclusky
Feb 8, 2005·Progress in Neuro-psychopharmacology & Biological Psychiatry·Omer AydemirFatma Taneli
Apr 6, 2005·European Archives of Psychiatry and Clinical Neuroscience·Ali Saffet GonulSimavi Vahip
Apr 12, 2005·European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology·Gal Shoval, Abraham Weizman
Oct 18, 2005·The Journal of Pharmacology and Experimental Therapeutics·Miao-Kun Sun, Daniel L Alkon

❮ Previous
Next ❯

Citations

Feb 11, 2011·Psychopharmacology·Montserrat Serra-MillàsCristóbal Gastó
Oct 15, 2011·Archives of Women's Mental Health·Erika ComascoAlkistis Skalkidou
Dec 30, 2011·Cellular and Molecular Neurobiology·Qing-Qiu MaoChun-Tao Che
Dec 7, 2010·Acta Pharmacologica Sinica·Hui Yu, Zhe-yu Chen
May 21, 2009·Molecular Psychiatry·C Langan, C McDonald
Aug 6, 2010·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Heath D Schmidt, Ronald S Duman
Aug 5, 2011·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Heath D SchmidtRonald S Duman
Jul 28, 2011·Neuropsychiatric Disease and Treatment·Craig HilburnMichael J Forster
Sep 23, 2014·Acta Neuropsychiatrica·Salih Saygin EkerEmre Sarandol
Jan 18, 2014·Aging Clinical and Experimental Research·Antonio MartocchiaPaolo Falaschi
Apr 9, 2013·The Psychiatric Quarterly·Stefania Pigatto TecheNeusa Sica Rocha
Oct 14, 2014·Acta Neuropsychiatrica·Majda GrahSilvana Jelavic
Sep 3, 2014·Progress in Neuro-psychopharmacology & Biological Psychiatry·Masahiro HashizumeKazushige Ihara
Jan 11, 2013·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Francis E LotrichRobert E Ferrell
Nov 22, 2011·Neurochemical Research·Marta GazalJean Pierre Oses
Aug 10, 2010·Pharmaceuticals·Michelle Roche, David P Finn
Oct 1, 2007·Expert Opinion on Medical Diagnostics·Enrico Domenici, Pierandrea Muglia
Jun 12, 2012·Journal of Psychiatric Research·Betina ElfvingOle Mors
Mar 10, 2011·Neuroscience Letters·Maaike GoekintRomain Meeusen
Dec 7, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·I D NeumannA A Mathé
Jul 21, 2010·Progress in Neuro-psychopharmacology & Biological Psychiatry·William BergerThomas C Neylan
May 16, 2009·Frontiers in Neuroendocrinology·Francesca Cirulli, Enrico Alleva
Dec 27, 2008·Progress in Neuro-psychopharmacology & Biological Psychiatry·Ayse Devrim BaşterziAylin Yazici

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.